Clinical Trial

Genetics and Environment iNtersection In the ALS-FTD Spectrum: an Italian Twins Cohort studY With a Multi-Omics Approach

Study acronym: GENIALITY
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 4, 2025 (before its estimated January 29, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to learn from discordant twins affected by Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia the contribution of genetic background versus environmental exposure. The main questions it aims to answer is: * How far does the genetic background explain the onset of ALS/FTD in discordant twins? * Which environmental factors and events occurring in post-fetal life influence the onset or progression of this neurodegenerative condition? Participants with ALS and/or FTD with a monozygotic or dizygotic twin willing to contribute to this research will be followed up for two years by specialized Motor Neuron Disorders centers in Italy, donating biological specimen for -omic sciences analysis, and checking out if prodromal signs/symptoms of these two conditions will develop during time.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-11; most recent amendment 2025-01-31.
Trial Details
NCT Number NCT06595212
Lead Sponsor Azienda Ospedaliero-Universitaria di Modena
Collaborators: A.O.U. Città della Salute e della Scienza - Molinette Hospital, Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Careggi
Conditions ALS, FTD
Enrollment 45 participants
Start Date 2024-01-29
Primary Completion 2026-01-29 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-04